Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Offord

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
The Biochemical Journal|December 1, 1976
Diazoalkanes in peptide semisynthesisR E Offord, H T Storey, A R Rees, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 19, 2000
Positive and negative labeling of human proinsulin, insulin, and C-peptide with stable isotopes. New tools for in vivo pharmacokinetic and metabolic studiesR Stöcklin, J F Arrighi, K Hoang-Van, et al.
Journal of Virology|April 10, 1999
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variantsD E Mosier, G R Picchio, R J Gulizia, et al.
The Journal of Biological Chemistry|November 5, 1999
Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptorsA E Proudfoot, R Buser, F Borlat, et al.
Journal of Virology|September 12, 2000
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infectionsS Rusconi, S La Seta Catamancio, P Citterio, et al.
Science (New York, N.Y.)|April 11, 1997
Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonistG Simmons, P R Clapham, L Picard, et al.
Journal of Virology|April 25, 2000
Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogsV S Torre, A J Marozsan, J L Albright, et al.
AIDS Research and Human Retroviruses|July 17, 1999
Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferationS Rusconi, S La Seta-Catamancio, S Kurtagic, et al.
The Journal of Experimental Medicine|November 21, 2000
Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explantsT Kawamura, S S Cohen, D L Borris, et al.
Journal of Virology|August 17, 2001
Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTESA J Marozsan, V S Torre, M Johnson, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
The Biochemical Journal|December 1, 1976
Diazoalkanes in peptide semisynthesisR E Offord, H T Storey, A R Rees, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 19, 2000
Positive and negative labeling of human proinsulin, insulin, and C-peptide with stable isotopes. New tools for in vivo pharmacokinetic and metabolic studiesR Stöcklin, J F Arrighi, K Hoang-Van, et al.
Journal of Virology|April 10, 1999
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variantsD E Mosier, G R Picchio, R J Gulizia, et al.
The Journal of Biological Chemistry|November 5, 1999
Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptorsA E Proudfoot, R Buser, F Borlat, et al.
Journal of Virology|September 12, 2000
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infectionsS Rusconi, S La Seta Catamancio, P Citterio, et al.
Science (New York, N.Y.)|April 11, 1997
Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonistG Simmons, P R Clapham, L Picard, et al.
Journal of Virology|April 25, 2000
Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogsV S Torre, A J Marozsan, J L Albright, et al.
AIDS Research and Human Retroviruses|July 17, 1999
Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferationS Rusconi, S La Seta-Catamancio, S Kurtagic, et al.
The Journal of Experimental Medicine|November 21, 2000
Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explantsT Kawamura, S S Cohen, D L Borris, et al.
Journal of Virology|August 17, 2001
Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTESA J Marozsan, V S Torre, M Johnson, et al.
Pageof 12